[
    [
        {
            "time": "2018-06-04",
            "original_text": "Here’s What Hedge Funds Think About Eli Lilly and Company (LLY)",
            "features": {
                "keywords": [
                    "Hedge Funds",
                    "Eli Lilly",
                    "LLY"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Here’s What Hedge Funds Think About Eli Lilly and Company (LLY)",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-05-15",
            "original_text": "Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache",
            "features": {
                "keywords": [
                    "ASCO",
                    "FDA",
                    "LLY",
                    "Emgality",
                    "Cluster Headache"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]